Sort
30,917 grants matching “tumor microenvironment”
CD8+ T Cells and Immunological Tumor Regression
$1,438,871University Of Chicago · P01 · FY2003 · CA
Human Melanoma: Etiology, Progression and Therapy
$1,438,284Meenhard Herlyn · Wistar Institute · P01 · FY2014 · CA
JPL Task Plan 82-16333, Development of the EDRN Informatics Center in Support of Biomarker Research and Validation
$1,437,578Dan Crichton · National Cancer Institute · Y01 · FY2017 · CA
Resource for Molecular Imaging Agents in Precision Medicine
$1,436,774Martin G Pomper · Ut Southwestern Medical Center · P41 · FY2024 · EB
Cellular In vivo Imaging
$1,435,868Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The Role of Protein Methylation in Squamous Cell Carcinoma of the Head and Neck
$1,435,614Vassiliki Saloura · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,434,683Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Modulation of Therapeutic Response
$1,432,969James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells
$1,432,735Gisela Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center
$1,431,641Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2025 · CA
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
$1,431,221Melanie Hayden Gephart · Stanford University · U54 · FY2024 · CA
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
$1,430,472David E Fisher · Massachusetts General Hospital · P01 · FY2022 · CA
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,428,684Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
$1,428,421David E Fisher · Massachusetts General Hospital · P01 · FY2023 · CA
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center
$1,428,096Phuoc T. Tran · University Of Maryland Baltimore · U54 · FY2024 · CA
p53 - Regulators and Effectors
$1,424,298Stuart A Aaronson · Icahn School Of Medicine At Mount Sinai · P01 · FY2011 · CA
HIV integration-mediated modulation of immune regulation in HPV-associated cancers
$1,423,275Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2019 · CA
Human Melanoma: Etiology, Progression and Therapy
$1,422,871Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA
Human Melanoma: Etiology, Progression and Therapy
$1,421,890Meenhard Herlyn · Wistar Institute · P01 · FY2012 · CA
In vivo efficacy, safety and PK/PD analysis of SYN101, a first in class, immune cell targeted TGFb therapy for cancer patients
$1,420,853Dori A Thomas-Karyat · Synthis Therapeutics, Inc. · R44 · FY2025 · CA
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
$1,419,991Lynn M Matrisian · Vanderbilt University · U54 · FY2010 · CA
p53 - Regulators and Effectors
$1,419,497Stuart A Aaronson · Icahn School Of Medicine At Mount Sinai · P01 · FY2012 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,418,557Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,418,261Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center
$1,416,545Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA